UNSPSC 51281517: Fenamisal

This classification denotes an antitubercular agent with the molecular formula C13H11NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 52936SIP7V, chemically known as salicylic acid, 4-amino-, phenyl ester (8ci) but more generally known as fenamisal, which bears US NIH Compound Identifier 8609. European Medicines Agency schedules Fenamisal in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07538MIG. The term FENAMISAL is an International Non-Proprietary Name.

FENAMISAL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: O(C(=O)C1C(O)CC(N)CC1)C1CCCCC1.

UNSPSC 51281517 Fenamisal, a Commodity code, addresses pharmaceutical and medical product procurement by state and local health and safety agencies, though recent state and local solicitations show minimal activity specifically tied to this code. The recent opportunities posted under this code include medical and first aid supplies (respiratory equipment, cardiac monitoring electrodes, endotracheal tubes, bandaging materials, oxygen systems) for emergency response; generic multi-source pharmaceuticals and over-the-counter products distributed through authorized wholesalers to state and local facilities; and direct-to-manufacturer prescription programs designed to improve pharmacy benefit fulfillment. Issuing bodies include county health departments, municipal fire departments, state health and human services commissions, and multistate cooperative purchasing alliances. The City of Tampa's Purchasing Department, Seminole County (Florida), the Texas Health and Human Services Commission, and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) represent the recent buyer base, spanning health delivery, emergency services, and pharmacy benefit administration.

Activity concentrates in Florida and Minnesota, with Texas representing early-stage market research. The City of Tampa issued IFB 26P00145 for medical and first aid supplies to the Tampa Fire Department Rescue Division, due March 13, 2026, with an estimated contract value of $700,000 and a 5 percent bid discount for certified Small Local Business Enterprises. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries and a response deadline of July 26, 2023. The Minnesota Department of Administration issued an RFP (S1070000015802) through MMCAP on January 20, 2026, for generic multi-source pharmaceuticals and OTC products, with proposals due March 26, 2026, and awarded vendors to be provided to authorized wholesalers by May 15, 2026. The Texas Health and Human Services Commission released an RFI (HHS0017013) on March 27, 2026, gathering vendor capability data on direct-to-manufacturer prescription programs, posted as market intelligence rather than a formal competitive solicitation.